ABK Biomedical will use the facility, near the Columbia Regional Airport, to produce a technology used to treat patients with ...
ABK Biomedical is building a Missouri facility to produce Eye90 microspheres, advancing radiopharmaceuticals for liver cancer ...
HALIFAX, NS, April 8, 2026 /PRNewswire/ - ABK Biomedical, Inc. and COR Development are proud to announce a strategic partnership to develop a state-of-the-art GMP manufacturing facility in Cartwright ...
HALIFAX, NS, March 31, 2026 /PRNewswire/ - ABK Biomedical and the University of Missouri Research Reactor (MURR) are powering the next generation of cancer treatment. Today, the two partners signed a ...
The MU Research Reactor has partnered with ABK Biomedical to conduct an in-person clinical trial targeted at finding a treatment for liver tumors.
HALIFAX, NS, Oct. 14, 2025 /CNW/ - ABK Biomedical, Inc., an innovative medical device company dedicated to the research, development, and commercialization of advanced imageable embolic medical ...